a220202rmadorecronossect

0001656472-22-000058.txt : 20220317 0001656472-22-000058.hdr.sgml : 20220317 20220317175832 ACCESSION NUMBER: 0001656472-22-000058 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 3 CONFORMED PERIOD OF REPORT: 20220315 FILED AS OF DATE: 20220317 DATE AS OF CHANGE: 20220317 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Madore Robert L CENTRAL INDEX KEY: 0001555256 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-38403 FILM NUMBER: 22750160 MAIL ADDRESS: STREET 1: C/O RALPH LAUREN CORPORATION STREET 2: 650 MADISON AVENUE CITY: NEW YORK STATE: NY ZIP: 10022 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Cronos Group Inc. CENTRAL INDEX KEY: 0001656472 STANDARD INDUSTRIAL CLASSIFICATION: MEDICINAL CHEMICALS & BOTANICAL PRODUCTS [2833] IRS NUMBER: 000000000 STATE OF INCORPORATION: A6 FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 111 PETER STREET STREET 2: SUITE 300 CITY: TORONTO STATE: A6 ZIP: M5V 2H1 BUSINESS PHONE: (416) 504-0004 MAIL ADDRESS: STREET 1: 111 PETER STREET STREET 2: SUITE 300 CITY: TORONTO STATE: A6 ZIP: M5V 2H1 FORMER COMPANY: FORMER CONFORMED NAME: PharmaCan Capital Corp. DATE OF NAME CHANGE: 20151021 4 1 wf-form4_164755429116812.xml FORM 4 X0306 4 2022-03-15 0 0001656472 Cronos Group Inc. CRON 0001555256 Madore Robert L 111 PETER STREET SUITE 300 TORONTO A6 M5V 2H1 ONTARIO, CANADA 0 1 0 0 Chief Financial Officer RESTRICTED STOCK UNITS 2022-03-15 4 A 0 262500 0 A COMMON SHARES 262500.0 312500 D Each restricted stock unit ("RSU") represents a contingent right to receive one common share of Cronos Group Inc. The RSUs vest in three substantially equal annual installments beginning March 15, 2023, subject to continued employment through each applicable vesting date. Exhibit List: Exhibit 24 - Power of Attorney /s/ Aaron Werner, as attorney-in-fact for Robert L. Madore 2022-03-17 EX-24 2 a220202rmadorecronossect.htm EXHIBIT LIST: EXHIBIT 24 - POWER OF ATTORNEY (MADORE) a220202rmadorecronossect

Robert L. Madore – Exhibit 24 Authorization and Designation to Sign and File Section 16 Reporting Forms The undersigned does hereby authorize and designate each of Aaron Werner and Terry Doucet, each with right to substitute and resubstitute, but for only so long as each of them is an employee of Cronos Group Inc., a corporation incorporated under the Business Corporations Act (British Columbia) (the “Company”), to sign and file on his behalf the application for the required Securities and Exchange Commission (the “SEC”) electronic CIK/CCC codes and any and all Forms 3, 4 and 5 and Forms 144 relating to equity securities of the Company with the SEC pursuant to the requirements of Section 16 of the Securities Exchange Act of 1934, as amended (“Section 16”) and Rule 144 under the Securities Act of 1933, as amended. This authorization, unless earlier revoked in writing, shall be valid until the undersigned’s reporting obligations under Section 16 and Rule 144 with respect to equity securities of the Company shall cease. All prior such authorizations are hereby revoked. IN WITNESS WHEREOF, the undersigned has executed this Authorization and Designation this ____ day of _________________, 2022. Robert L. Madore DocuSign Envelope ID: E54E12E8-17E3-4B91-8116-82114B1EC142 2 February